New · CUSIP 68401U204 · who reports it, how much, and how much it matters to them
15 of the 720 hedge fund managers we track reported shares of OptimizeRx Corp (Nasdaq: OPRX) on Form 13F for 30 June 2026. Between them they reported USD 16m. The largest position belongs to Whetstone Capital Advisors, at USD 8.6m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Whetstone Capital Advisors2 funds on PPLI.com | USD 8.6m | 2.3% |
| 2 | Awm Investment Company6 funds on PPLI.com | USD 1.4m | 0.1% |
| 3 | Renaissance Technologies13 funds on PPLI.com | USD 959,000 | 0.0% |
| 4 | Marshall Wace LLP84 funds on PPLI.com | USD 928,000 | 0.0% |
| 5 | Citadel Advisors32 funds on PPLI.com | USD 904,000 | 0.0% |
| 6 | D. E. Shaw & Co.15 funds on PPLI.com | USD 790,000 | 0.0% |
| 7 | Millennium Management6 funds on PPLI.com | USD 451,000 | 0.0% |
| 8 | POINT72 Asset Management17 funds on PPLI.com | USD 318,000 | 0.0% |
| 9 | Jain Global1 fund on PPLI.com | USD 296,000 | 0.0% |
| 10 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 292,000 | 0.0% |
| 11 | Squarepoint Ops7 funds on PPLI.com | USD 258,000 | 0.0% |
| 12 | Samjo Management2 funds on PPLI.com | USD 183,000 | 0.1% |
| 13 | 9823 Capital2 funds on PPLI.com | USD 141,000 | 0.1% |
| 14 | Engineers Gate Manager1 fund on PPLI.com | USD 100,000 | 0.0% |
| 15 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 81,377 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Whetstone Capital Advisors | USD 8.6m | 2.3% |
| 2 | Awm Investment Company | USD 1.4m | 0.1% |
| 3 | 9823 Capital | USD 141,000 | 0.1% |
| 4 | Samjo Management | USD 183,000 | 0.1% |
| 5 | Campbell & Company Investment Adviser | USD 292,000 | 0.0% |
| 6 | Renaissance Technologies | USD 959,000 | 0.0% |
| 7 | Marshall Wace LLP | USD 928,000 | 0.0% |
| 8 | Jain Global | USD 296,000 | 0.0% |
| 9 | Engineers Gate Manager | USD 100,000 | 0.0% |
| 10 | Citadel Advisors | USD 904,000 | 0.0% |
OptimizeRx Corp trades under the symbol OPRX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 68401U204.
15 of the 720 hedge fund managers PPLI.com tracks reported OptimizeRx Corp shares on Form 13F for 30 June 2026. The largest reported positions were held by Whetstone Capital Advisors (USD 8.6m), Awm Investment Company (USD 1.4m), Renaissance Technologies (USD 959,000), Marshall Wace LLP (USD 928,000) and Citadel Advisors (USD 904,000).
15 managers in our coverage reported it, and between them they run 226 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Whetstone Capital Advisors, where the position was 2.3% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with OptimizeRx Corp or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.